More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$19.19B
EPS
3.96
P/E ratio
21.6
Price to sales
2
Dividend yield
0.947%
Beta
0.491356
Previous close
$103.21
Today's open
$104.03
Day's range
$99.70 - $104.03
52 week range
$79.12 - $112.55
show more
CEO
Ivan Tornos
Employees
17000
Headquarters
Warsaw, IN
Exchange
New York Stock Exchange
Shares outstanding
189253888
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Zimmer Biomet to Present at the Annual Jefferies Global Healthcare Conference in London
WARSAW, Ind., Nov. 9, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will be presenting at the Annual Jefferies Global Healthcare Conference in London on Thursday, November 19 at 1:00 p.m.
PRNewsWire • Nov 9, 2026

What Zimmer Biomet (ZBH) Said on Its Q3 Earnings Call
Zimmer Biomet NYSE: ZBH raised its 2026 sales growth and adjusted earnings outlook after third-quarter growth in hips, surgical specialties and technology offset continued weakness in its knee business.
MarketBeat • Nov 8, 2026

Zimmer Biomet Introduces Surgeon-Guided Autonomy, a New Category in Intelligent Surgery
New Category Will Introduce a Closed-Loop Framework: Predict. Perform. Recover.
PRNewsWire • Nov 6, 2026

Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Nov 5, 2026

Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 4, 2026

Zimmer Biomet Announces Third Quarter 2026 Financial Results
Third quarter net sales of $2.063 billion increased 3.1% on a reported basis and 3.7% on a constant currency1 basis Third quarter diluted earnings per share were $1.00, a decrease of 13.8%; adjusted1 diluted earnings per share were $1.90, consistent with the prior year period Company updates full-year 2026 financial guidance WARSAW, Ind., Nov. 4, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2026.
PRNewsWire • Nov 4, 2026

Zimmer Biomet Lifts Annual Growth Despite Challenging Knee Market
Zimmer Biomet Holdings (NYSE:ZBH) stock is trading at a 52-week high after the better-than-expected third-quarter earnings.
Benzinga • Nov 4, 2026

Zimmer Biomet (ZBH) Q3 Earnings and Revenues Beat Estimates
Zimmer Biomet (ZBH) came out with quarterly earnings of $1.9 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $1.9 per share a year ago.
Zacks Investment Research • Nov 4, 2026

Zimmer (ZBH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Zimmer (ZBH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Nov 4, 2026

Zimmer Biomet Stock Up on Q3 Earnings & Revenue Beat, '26 View Up
ZBH beats Q3 earnings and revenue estimates, lifting its 2026 outlook as strong Hips and S.E.T. sales offset weakness in Knees amid margin pressure.
Zacks Investment Research • Nov 4, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Zimmer Biomet Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.